Judith E. Fradkin, MD; Griffin P. Rodgers, MD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-2883.
Requests for Single Reprints: Judith E. Fradkin, MD, MSC 2560, 6707 Democracy Boulevard, Bethesda, MD 20892; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Fradkin: MSC 2560, 6707 Democracy Boulevard, Bethesda, MD 20892.
Dr. Rodgers: 31 Center Drive, Room 9A52, Bethesda, MD 20892.
Author Contributions: Conception and design: J.E. Fradkin.
Drafting of the article: J.E. Fradkin, G.P. Rodgers.
Critical revision for important intellectual content: G.P. Rodgers.
Final approval of the article: J.E. Fradkin, G.P. Rodgers.
Fradkin JE, Rodgers GP. Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind. Ann Intern Med. [Epub ahead of print 3 January 2017]:. doi: 10.7326/M16-2883
Download citation file:
Published: Ann Intern Med. 2017.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Endocrine and Metabolism, Diabetes, Coronary Risk Factors.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only